Metastatic pancreatic cancer now in remission: a case report and literature review
Abstract Pancreatic cancer is a highly aggressive malignancy with the majority of patients presenting at a late stage with unresectable or metastatic disease. Even with first line treatment, median survival is approximately 11 months in patients with advanced PDAC. This report details the unique cas...
Saved in:
Main Authors: | Charles W. Shi, Thomas J. VanderMeer, Anita Pudusseri |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer
2025-01-01
|
Series: | Discover Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1007/s12672-025-01756-4 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cost-effectiveness of systematic chemotherapy for metastatic pancreatic cancer: a retrospective study using Japanese clinical data
by: Akira Shinohara, et al.
Published: (2025-01-01) -
Global metabolomic profiling of tumor tissue and paired serum samples to identify biomarkers for response to neoadjuvant FOLFIRINOX treatment of human pancreatic cancer
by: Manoj Amrutkar, et al.
Published: (2025-02-01) -
Survival benefits of adjuvant chemotherapy after conversion surgery in patients with advanced pancreatic cancer
by: Yoon Suk Lee, et al.
Published: (2025-01-01) -
Microbiome in pancreatic cancer – What is new in 2024?
by: E. Hohmann, et al.
Published: (2024-10-01) -
Diagnostic and therapeutic recommendations in pancreatic ductal adenocarcinoma. Recommendations of the Working Group of the Polish Pancreatic Club
by: Katarzyna Winter, et al.
Published: (2019-03-01)